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A fall 2016 outbreak of enterovirus D68 infection in St. Louis, Missouri, USA, had less effect than a fall 2014 outbreak
on hospital census, intensive care unit census, and hospitalization for a diagnosis of respiratory illness. Without ongoing surveillance and specific testing, these cases might
have been missed.

T

he largest known outbreak of enterovirus D68 (EVD68) occurred in the United States in 2014 (1). Severe respiratory illnesses increased in fall of 2014, corresponding to a period when EV-D68 was present in the
community, at St. Louis Children’s Hospital (St. Louis,
Missouri, USA) and elsewhere in the United States (1,2).
Multiple reports suggested that the predominant virus
was from clade B1, although some viruses from clades
B2 were also detected (3–5). During 2015, there were few
reports of EV-D68 circulating in the United States (6);
however, in 2016, EV-D68 reappeared in multiple US locations (New York, Colorado); virus sequences suggested
that the predominant virus was from clade B3 (4,7). We
also documented EV-D68 activity in St. Louis in 2016.
Sequencing of viruses from 2 patients tested in the St.
Louis Children’s Hospital virology laboratory revealed
clade B3 with 99% identity to the clade B3 virus from
New York (8). Our goal with this study was to determine
if the 2016 outbreak had caused an increase in hospital
census or increase in patients admitted with respiratory
diagnosis, as was seen during the 2014 outbreak.
During August 7, 2016, through December 16, 2016,
we used a previously described EV-D68–specific PCR to
test 5%–10% of enterovirus/rhinovirus–positive samples
submitted each week to the St. Louis Children’s Hospital diagnostic virology laboratory. The samples had been
obtained from patients seen at the hospital’s emergency
department or clinics or admitted to the inpatient units
and had been routinely tested by a FilmArray Respiratory
Panel (BioFire, Salt Lake City, UT, USA) (9). Samples
were selected by laboratory staff without regard to patient
characteristics and were deidentified before EV-D68 testing. We obtained inpatient and intensive care unit (ICU)
census data for all patients (not limited to those with a
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respiratory diagnosis) and discharge diagnoses for hospitalized patients from the hospital’s Health Information
Management System, an administrative database, for
2013–2016.
Discharge diagnoses were categorized as respiratory
or nonrespiratory. A respiratory diagnosis was defined as
any principal diagnosis referring to disease processes of the
respiratory tract (e.g., asthma exacerbation, bronchiolitis,
respiratory distress, respiratory failure, pneumonia). We
used the Pearson χ2 test of independence to compare the
frequency distribution of patients with a respiratory diagnosis in 2014 and 2016 with frequency of those in 2013
and 2015 combined. All analyses were done with SAS/
STAT software version 9.4 for Windows (SAS Institute,
Cary, NC, USA). The Washington University Institutional
Review Board determined that this project did not meet the
definition of human subject research and, as such, was not
subject to institutional review board review.
During August 7–November 5, 2016, we tested a total of 4,190 samples by using the viral respiratory panel;
1,058 (25%) were positive for rhinovirus/enterovirus.
Further testing of 179 samples positive for rhinovirus/
enterovirus revealed that 19 (11%) were positive for EVD68 (online Technical Appendix Figure, panel A, https://
wwwnc.cdc.gov/EID/article/24/11/18-0397-Techapp1.
pdf). During November 6–26, 2016, we tested 47 rhinovirus/enterovirus–positive samples, and 4/47 (9%) were
positive for EV-D68. During November 27–December
10, 2016, we tested 33 rhinovirus/enterovirus–positive
samples, and none were positive for EV-D68. We did not
include EV-D68 testing data from November 6–December 10, 2016, in the online Technical Appendix Figure
because of the difficulty in obtaining discharge diagnosis
data (changes in registration systems affected data collection during that period).
In contrast to the experience in 2014, overall inpatient
or ICU census did not increase during this outbreak except
for a 1–2 week period in October (online Technical Appendix Figure, panels B–D). During August 7–November
5, 2014, the number and percentage of patients hospitalized with a respiratory diagnosis increased significantly
(852/5,894, 14%) compared with the corresponding periods in 2013 and 2015 combined (1,156/10,958, 11%;
p<0.0001). This increase in patients hospitalized with respiratory diagnoses in 2014 overlapped with the increase
in EV-D68 activity in our hospital. In 2014, we tested 572
rhinovirus/enterovirus–positive specimens from August 3,
2104–October 31, 2014, and 159 (28%) were positive for
EV-D68 (2). In contrast, the number and percentage of patients admitted with a respiratory diagnosis during August
7–November 5, 2016, decreased significantly (483/5,304,
9%) compared with the corresponding periods in 2013 and
2015 combined (p = 0.004).
2116

The overall effects of the 2016 outbreak seem to have
been less than those of the 2014 outbreak. The epidemiologic
data from our hospital, which has a broad catchment area in
the central United States, confirm that the period of EV-D68
activity in 2016 had less effect on hospital census, ICU census, and hospitalization for respiratory diagnosis than that
in 2014. Although the measured parameters are relatively
crude, we found no changes in data collection procedures
that explain the observed differences, suggesting that the differences are the result of lower levels of EV-D68 circulation
in the population in 2016. Our study suggests that surveillance using specific testing is needed to detect EV-D68 activity, which would have been missed if we had monitored
only for increases in patients with respiratory diagnoses or
hospital census.
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Among students with influenza-like illness at a Pennsylvania college student health center during 2016–2017, 44
(15%) of 288 with respiratory specimens tested positive
for human adenovirus (HAdV). HAdV-3, -7, and -4 predominated, and types clustered temporally. HAdV infection
should be considered among college students with acute
respiratory illness.

H

uman adenoviruses (HAdVs) cause a range of clinical manifestations, most commonly acute respiratory
illness (ARI), gastroenteritis, and conjunctivitis. Seven
HAdV species (A–G) and >80 types are known to cause
human infection, and certain HAdV types are associated
with particular tissue tropisms and clinical syndromes (1).
Outbreaks of HAdV infection occur in a variety of settings,
including schools, long-term care facilities, military recruit

training facilities, and the civilian community (2–4). The
substantial impact of HAdV ARI among US military recruits drove development of the first live oral vaccine for
HAdV types 4 and 7 for military use. After vaccine introduction in 1971, and again after reintroduction in 2011,
dramatic declines were documented in respiratory illness
among recruits (5). Currently, the HAdV vaccine for types
4 and 7 is licensed in the United States for use in military
personnel 17–50 years of age and is administered routinely
at all US basic military training sites (5). However, despite
some similarities between military recruits and civilian college students, including age and sharing of residences, little
is known about the contribution of HAdV to respiratory illness in college students.
The Pennsylvania Department of Health (PDH) conducts surveillance for influenza-like illness (ILI), defined
as fever (temperature >100°F [>37.8°C]) plus cough or
sore throat without a known cause other than influenza,
at participating outpatient healthcare facilities throughout
the state. Basic demographic information is recorded, and
from a convenience sample of cases, a nasopharyngeal
swab specimen is collected. These specimens are tested by
the PDH Bureau of Laboratories using Centers for Disease
Control and Prevention (CDC) real-time reverse transcription PCR for influenza A and B, HAdV, respiratory syncytial virus, human metapneumovirus, rhinovirus, and parainfluenza virus types 1–3.
We describe HAdV types associated with ILI among
students who sought care at a student health center (SHC)
on a large college campus during August 28, 2016–August
26, 2017. Specimens identified as HAdV-positive among
students with ILI at the SHC were sent to CDC to determine HAdV species and type. Molecular typing was performed by PCR and sequencing of the hexon hypervariable
regions 1–6 (6).
During the study period, 1,149 ILI cases were reported from the SHC; for 288 (25%), a nasopharyngeal swab
specimen was tested for respiratory viruses (Figure, panel
A). Of these, 44 (15%) specimens were positive for HAdV.
Three HAdV species and 4 HAdV types were detected:
HAdV-3 and HAdV-7 of species HAdV-B in 21 (48%) and
16 (36%), respectively; HAdV-4 of species HAdV-E in 5
(11%); and HAdV-1 of species HAdV-C in 2 (5%). The
median age of HAdV-positive students was 19 years (range
18–27 years), and 31 (70%) were male. Among HAdVpositive specimens, rhinovirus was co-detected in 4 and
parainfluenza virus type 2 in 1.
HAdV-3 was identified during September–December;
no additional HAdV-3 was identified after the 4-week winter break. HAdV-7 and -4 were first detected in December,
before winter break, then throughout the spring; HAdV-7
was the most commonly detected type during this period
(Figure, panel B).
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Technical Appendix

Technical Appendix Figure. Numbers of samples tested for enterovirus D68 (A), number of patients with
respiratory diagnosis (B), and inpatient (C) and intensive care unit (D) daily census for patients admitted
for any illness to St. Louis Children’s Hospital, St. Louis, Missouri, USA, 2013–2016. Discharge
diagnoses were categorized as respiratory or nonrespiratory. Respiratory diagnoses were defined as any
principal diagnosis referring to disease process of the respiratory tract.
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